UTMD Живые сигналы | Максимизируйте прибыль с Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 апр. 2024 @ 23:00):

Stats
Объем за сегодня	22 139.00
Средний объем	31 042.00
Рыночная капитализация	236.59M
EPS	$0 ( 2024-04-25 )
Дата следующего отчета о доходах	( $0 ) 2024-07-23
Last Dividend	$0.300 ( 2023-12-14 )
Next Dividend	$0 ( N/A )
P/E	14.42
ATR14	$0.158 (0.24%)

Insider Trading

Date	Person	Action	Amount	type
2023-10-27	Koopman Brian	Buy	500	Employee Stock Option - Right to Buy
2023-06-15	Koopman Brian	Sell	60	Common Stock
2023-05-18	Richins Paul O	Sell	700	Common Stock
2023-03-17	Richins Paul O	Sell	150	Common Stock
2023-02-08	Payne Barbara A	Sell	500	Common Stock

INSIDER POWER
-23.20
Last 100 transactions
Buy: 7 349 \| Sell: 108 142

Utah Medical Products Inc Корреляция

10 Самые положительные корреляции

10 Самые отрицательные корреляции

Вы знали?

Корреляция - это статистический показатель, описывающий связь между двумя переменными. Он изменяется от -1 до 1, где -1 указывает на идеальную отрицательную корреляцию (при увеличении одной переменной другая уменьшается), 1 указывает на идеальную положительную корреляцию (при увеличении одной переменной другая увеличивается), а 0 указывает на отсутствие корреляции (между переменными нет связи).

Корреляцию можно использовать для анализа связи между любыми двумя переменными, не только акциями. Она широко используется в таких областях, как финансы, экономика, психология и т. д.

Utah Medical Products Inc Корреляция - Валюта/Сырье

0.76
( moderate )

0.74
( moderate )

0.00
( neutral )

0.59
( weak )

-0.53
( weak negative )

-0.79
( moderate negative )

Utah Medical Products Inc Финансовые показатели

Annual	2023
Выручка:	$50.22M
Валовая прибыль:	$24.35M (48.47 %)
EPS:	$4.58

FY	2023
Выручка:	$50.22M
Валовая прибыль:	$24.35M (48.47 %)
EPS:	$4.58

FY	2022
Выручка:	$52.28M
Валовая прибыль:	$32.20M (61.58 %)
EPS:	$4.53

FY	2021
Выручка:	$49.05M
Валовая прибыль:	$30.92M (63.03 %)
EPS:	$4.15

Financial Reports:

No articles found.

Utah Medical Products Inc Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0.290 (N/A)	$0.295 (N/A)	$0.295 (N/A)	$0.295 (N/A)	$0.295 (N/A)	$0.300 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Utah Medical Products Inc Dividend Information - Dividend King

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 7.46 - Increase likely (49.15%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	$0.150	2004-06-14
Last Dividend	$0.300	2023-12-14
Next Dividend	$0	N/A
Payout Date	2024-01-03
Next Payout Date	N/A
# dividends	79	--
Total Paid Out	$21.80	--
Avg. Dividend % Per Year	1.09%	--
Score	5.45	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	7.46
Div. Directional Score	9.10	--

Next Divdend (Est)
(2024-07-01)

$0.301 Estimate 39.87 %

Dividend Stability

0.80 Good

Dividend Score

5.45

Pay Frequency

Quarterly

Yearly Payout

Year	Amount	Yield
2004	$0.450	1.75%
2005	$0.630	2.84%
2006	$0.780	2.55%
2007	$0.885	2.68%
2008	$0.905	3.06%
2009	$0.925	3.86%
2010	$1.665	5.63%
2011	$0.945	3.50%
2012	$0.965	3.53%
2013	$0.985	2.57%
2014	$1.005	1.94%
2015	$1.025	1.77%
2016	$1.045	1.78%
2017	$1.065	1.49%
2018	$1.085	1.37%
2019	$1.105	1.30%
2020	$1.125	1.05%
2021	$2.86	3.41%
2022	$1.165	1.20%
2023	$1.185	1.21%
2024	$0	0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Furthermore, its high Dividend Growth Potential Score (DGPS) signals potential dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for NASDAQ

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
PSEC	Dividend Royal	2023-12-26	Monthly	21	7.04%	8.50
SLVO	Dividend Royal	2023-11-20	Monthly	12	10.77%	8.50
QYLD	Dividend Royal	2023-11-20	Monthly	11	7.50%	8.50
GAIN	Dividend Royal	2023-12-04	Monthly	20	8.19%	8.50
GLDI	Dividend Royal	2023-11-20	Monthly	12	7.15%	8.50
OXLC	Dividend Royal	2023-12-14	Monthly	14	10.00%	8.50
OXSQ	Dividend Diamond	2023-12-14	Monthly	21	9.10%	8.50
HRZN	Dividend King	2023-12-18	Monthly	15	6.60%	8.45
USOI	Dividend Royal	2023-11-20	Monthly	8	16.70%	8.28
PFLT	Dividend King	2023-11-15	Monthly	14	6.50%	8.27

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.393	1.500	2.15	3.22	[0 - 0.5]
returnOnAssetsTTM	0.123	1.200	5.91	7.09	[0 - 0.3]
returnOnEquityTTM	0.135	1.500	9.61	10.00	[0.1 - 1]
payoutRatioTTM	0.257	-1.000	7.43	-7.43	[0 - 1]
currentRatioTTM	22.56	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	59.87	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	19.72	1.500	10.00	10.00	[0.2 - 2]
debtRatioTTM	0.00252	-1.500	9.96	-10.00	[0 - 0.6]
interestCoverageTTM	-8.51	1.000	-4.26	-4.26	[3 - 30]
operatingCashFlowPerShareTTM	6.14	2.00	7.95	10.00	[0 - 30]
freeCashFlowPerShareTTM	5.96	2.00	7.02	10.00	[0 - 20]
debtEquityRatioTTM	0.00267	-1.500	9.99	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.503	1.000	4.95	4.95	[0.2 - 0.8]
operatingProfitMarginTTM	0.354	1.000	4.92	4.92	[0.1 - 0.6]
cashFlowToDebtRatioTTM	65.15	1.000	10.00	10.00	[0.2 - 2]
assetTurnoverTTM	0.313	0.800	-1.248	-0.998	[0.5 - 2]
Total Score				10.73

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	14.38	1.000	8.65	0	[1 - 100]
returnOnEquityTTM	0.135	2.50	9.75	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	5.96	2.00	8.01	10.00	[0 - 30]
dividendYielPercentageTTM	1.805	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	6.14	2.00	7.95	10.00	[0 - 30]
payoutRatioTTM	0.257	1.500	7.43	-7.43	[0 - 1]
pegRatioTTM	1.407	1.500	3.95	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.526	1.000	10.00	0	[0.1 - 0.5]
Total Score				7.46

Utah Medical Products Inc

Utah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry. The company offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. It also provides GESCO umbilical vessel catheters; DIALY-NATE disposable peritoneal dialysis sets; PALA-NATE silicone oral protection devices; URI-CATH urinary drainage systems; NUTRI-CATH\NUTRI-LOK feeding device; MYELO-NATE lumbar sampling kits; HEMO-NATE disposable filters; and catheterization procedure tray of instruments and supplies. In addition, the company offers LETZ system to excise cervical intraepithelial neoplasia and other lower genital tract lesions; FINESSE+ generators; loop, ball, and needle electrodes; FILTRESSE evacuators; other specialty electrodes and supplies, and gynecologic tools; Femcare trocars, cannulae, laparoscopic instruments, and accessories; and EPITOME and OptiMicro electrosurgical devices. Further, it provides Filshie Clip female surgical contraception devices; PATHFINDER PLUS endoscopic irrigation devices; suprapubic catheterization; LIBERTY urinary incontinence treatment and control systems; ENDOCURETTE, a curette for uterine endometrial tissue sampling; TVUS/HSG-Cath to assess abnormal or dysfunctional uterine bleeding and other abnormalities of uterus; and LUMIN tool to manipulate the uterus in laparoscopic procedures. Additionally, the company offers DELTRAN, a disposable pressure transducer; and pressure monitoring accessories, components, and other molded parts. It serves neonatal intensive care units, labor and delivery departments, women's health centers in hospitals, outpatient clinics, and physician's offices through direct customer service and sales force, independent consultants, and manufacturer representatives. The company was incorporated in 1978 and is headquartered in Midvale, Utah.